Estrella Immunopharma
ESLA
ESLA
16 hedge funds and large institutions have $5.49M invested in Estrella Immunopharma in 2026 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
7% more funds holding
Funds holding: 15 → 16 (+1)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.71M | |
| 2 | +$304K | |
| 3 | +$54.8K | |
| 4 |
US Bancorp
Minneapolis,
Minnesota
|
+$19.4K |
| 5 |
BlackRock
New York
|
+$15.4K |
Top Sellers
| 1 | -$100K | |
| 2 | -$87.7K | |
| 3 | -$77.2K | |
| 4 |
Renaissance Technologies
New York
|
-$68.6K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$43.3K |
